Tech Company Financing Transactions
Farady Pharmaceuticals Funding Round
Farady Pharmaceuticals closed a $5.7 million investment round on 9/30/2014. Backers included Polaris Partners and private investors.
Transaction Overview
Company Name
Announced On
9/30/2014
Transaction Type
Venture Equity
Amount
$5,700,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1616 Eastlake Ave. E. 560
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Email Address
Not Recorded
Overview
The company is developing as-yet unspecified pharmaceutical products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Gillis
Browse more venture capital transactions:
Prev: 9/30/2014: Reciprocal Labs venture capital transaction
Next: 9/30/2014: Cleveland Heartlab venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs